Needle-shaped polymeric particles induce transient disruption of cell membranes

Journal of the Royal Society Interface

Volumn 7, Issue SUPPL. 4, 2010, Pages

  Doshi, Nishit ^a   Mitragotri, Samir ^a  

^a University of California   (United States)

Author keywords

Drug delivery; Nanoparticle; Nanotoxicology; Nanotube; Shape; Toxicity

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; CAPILLARITY; CELL MEMBRANES; CYTOLOGY; DRUG DELIVERY; NANOPARTICLES; NANOTUBES; NEEDLES; SURFACE CHEMISTRY; TOXICITY;

CALCEIN; CELL SPREADING; EXTRACELLULAR; LACTATE DEHYDROGENASE; MICRO-PARTICLES; NANOTOXICOLOGY; PARTICLE GEOMETRIES; PARTICLE PARAMETERS; POLYMERIC PARTICLES; SHAPE; SHAPED PARTICLES; TIME-PERIODS;

ENDOTHELIAL CELLS;

CALCEIN; LACTATE DEHYDROGENASE; NANOPARTICLE; POLYMER; POLYSTYRENE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL MOTILITY; CELL SHAPE; CELL SPREADING; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; ENZYME RELEASE; MEMBRANE DAMAGE; MOUSE; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; SURFACE PROPERTY;

EID: 77955719213     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2010.0134.focus     Document Type: Article

References (43)

1. Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. 2008 Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505-515. (doi:10.1021/mp800051m)
2. Allen, T. M. & Cullis, P. R. 2004 Drug delivery systems: entering the mainstream. Science 303, 1818-1822. (doi:10.1126/science.1095833)
3. Beningo, K. A. & Wang, Y. L. 2002 Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J. Cell Sci. 115, 849-856.
4. Brannon-Peppas, L. 1995 Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int. J. Pharm. 116, 1-9. (doi:10.1016/0378-5173(94)00324-X)
5. Brigger, I., Dubernet, C. & Couvreur, P. 2002 Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54, 631-651. (doi:10.1016/S0169- 409X(02)00044-3)
6. Canatella, P., Karr, J. F., Petros, J. A. & Prausnitz, M. R. 2001 Quantitative study of electroporation-mediated molecular uptake and cell viability. Biophys. J. 80, 755-764. (doi:10.1016/S0006-3495(01)76055-9)
7. Canelas, D., Herlihy, K. P. & DeSimone, J. M. 2009 Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. Wiley Interdisc. Rev.: Nanomed. Nanobiotechnol. 1, 391-404. (doi:10.1002/wnan.40)
8. Champion, J. A. & Mitragotri, S. 2006 Role of target geometry in phagocytosis. Proc. Natl Acad. Sci. USA 103, 4930-4934. (doi:10.1073/pnas. 0600997103)
9. Champion, J., Katare, Y. K. & Mitragotri, S. 2007a Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J. Control. Rel. 121, 3-9. (doi:10.1016/j.jconrel.2007.03.022)
10. Champion, J. A., Katare, Y. K. & Mitragotri, S. 2007b Making polymeric micro- and nanoparticles of complex shapes. Proc. Natl Acad. Sci. USA 104, 11 901-11 904. (doi:10.1073/pnas.0705326104)
11. Decuzzi, P., Godin, B., Tanaka, T., Lee, S.-Y., Chiappini, C., Liu, X. & Ferrari, M. 2009 Size and shape effects in the biodistribution of intravascularly injected particles. J. Control. Rel. 141, 320-327. (doi:10.1016/j.jconrel.2009.10.014)
12. Doshi, N. & Mitragotri, S. 2009 Designer biomaterials for nanomedicine. Adv. Funct. Mater. 19, 3843-3854. (doi:10.1002/adfm.200901538)
13. Doshi, N., Zahr, A. S., Bhaskar, S., Lahann, J. & Mitragotri, S. 2009 Red blood cell-mimicking synthetic biomaterial particles. Proc. Natl Acad. Sci. USA 106, 21 495-21 499. (doi:10.1073/pnas.0907127106)
14. Enayati, M., Ahmad, Z., Stride, E. & Edirisinghe, M. 2009 Preparation of polymeric carriers for drug delivery with different shape and size using an electric jet. Curr. Pharm. Biotechnol. 10, 600-608. (doi:10.2174/ 138920109789069323)
15. Farokhzad, O. & Langer, R. 2006 Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv. Drug Deliv. Rev. 58, 1456-1459. (doi:10.1016/j.addr.2006.09.011)
16. Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T. & Discher, D. E. 2007 Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2, 249-255. (doi:10.1038/nnano.2007. 70)
17. Gratton, S., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E. & DeSimone, J. M. 2008 The effect of particle design on cellular internalization pathways. Proc. Natl Acad. Sci. USA 105, 11 613-11 618. (doi:10.1073/pnas.0801763105)
18. Kang, S., Pinault, M., Pfefferle, L. D. & Elimelech, M. 2007 Single-walled carbon nanotubes exhibit strong antimicrobial activity. Langmuir 23, 8670-8673. (doi:10.1021/la701067r)
19. Kang, S., Herzberg, M., Rodrigues, D. F. & Elimelech, M. 2008 Antibacterial effects of carbon nanotubes: size does matter! Langmuir 24, 6409-6413. (doi:10.1021/la800951v)
20. Klumpp, C., Kosteralos, K., Prato, M. & Blanco, A. 2006 Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochim. Biophys. Acta Biomembr. 1758, 404-412. (doi:10.1016/j.bbamem.2005.10.008)
21. Lam, C., James, J. T., McCluskey, R. & Hunter, R. L. 2004 Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 77, 126-134. (doi:10.1093/toxsci/ kfg243)
22. Lam, C., James, J. T., McCluskey, R., Arepalli, S. & Hunter, R. L. 2006 A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. CRC Crit. Rev. Toxicol. 36, 189-217. (doi:10.1080/10408440600570233)
23. Langer, R. 1998 Drug delivery and targeting. Nature (Lond.) 392, 5-10.
24. Lindgren, M., Hällbrink, M., Prochiantz, A. & Langel, U. 2000 Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99-103. (doi:10.1016/S0165-6147(00)01447-4)
25. Mitragotri, S. & Lahann, J. 2009 Physical approaches to biomaterial design. Nat. Mater. 8, 15-23. (doi:10.1038/nmat2344)
26. Moghimi, S. M., Hunter, A. C. & Murray, J. C. 2001 Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53, 283-318.
27. Muro, S., Cui, X., Gajewski, C., Murciano, J.-C., Muzykantov, V. R. & Koval, M. 2003 Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. Am. J. Physiol. Cell Physiol. 285, C1339-C1347. (doi:10.1152/ajpcell.00099.2003)
28. Muro, S., Koval, M. & Muzykantov, V. 2004 Endothelial endocytic pathways: gates for vascular drug delivery. Curr. Vasc. Pharmacol. 2, 281-299. (doi:10.2174/1570161043385736)
29. Muro, S., Garnacho, C., Champion, J. A., Leferovich, J., Gajewski, C., Schuchman, E. H., Mitragotri, S. & Muzykantov, V. R. 2008 Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol. Ther. 16, 1450-1458. (doi:10.1038/mt.2008.127)
30. Owens III, D. E. & Peppas, N. A. 2006 Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307, 93-102. (doi:10.1016/j.ijpharm.2005.10.010)
31. Pantarotto, D., Briand, J.-P., Prato, M. & Bianco, A. 2004 Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. 2004, 16-17. (doi:10.1039/b311254c)
32. Park, J., von Maltzahn, G., Zhang, L., Schwartz, M. P., Ruoslahti, E., Bhatia, S. N. & Sailor, M. J. 2008 Magnetic iron oxide nanoworms for tumor targeting and imaging. Adv. Mater. 20, 1630-1635. (doi:10.1002/adma.200800004)
33. Roh, K., Martin, D. C. & Lahann, J. 2005 Biphasic Janus particles with nanoscale anisotropy. Nat. Mater. 4, 759-763. (doi:10.1038/nmat1486)
34. Ruoslahti, E. 2002 Drug targeting to specific vascular sites. Drug Discov. Today 7, 1138-1143. (doi:10.1016/S1359-6446(02)02501-1) (Pubitemid 35346421)
35. Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R. & Rudzinski, W. E. 2001 Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Rel. 70, 1-20. (doi:10.1016/S0168-3659(00)00339-4)
36. Sudimack, J. & Lee, R. 2000 Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41, 147-162. (doi:10.1016/S0169-409X(99)00062-9)
37. Sugahara, K., Teesalu, T., Karmali, P., Kotamraju, V., Agemy, L., Girard, O., Hanahan, D., Mattrey, R. & Ruoslahti, E. 2009 Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 16, 510-520. (doi:10.1016/j.ccr.2009.10.013)
38. Tachibana, K., Uchida, T., Ogawa, K., Yamashita, N. & Tamura, K. 1999 Induction of cell-membrane porosity by ultrasound. Lancet 353, 1409. (doi:10.1016/S0140-6736(99)01244-1)
39. Uhrich, K., Cannizaro, S. M., Langer, R. S. & Shakesheff, K. M. 1999 Polymeric systems for controlled drug release. Chem. Rev. 99, 3181-3198. (doi:10.1021/cr940351u)
40. Whitehead, K. & Mitragotri, S. 2008 Mechanistic analysis of chemical permeation enhancers for oral drug delivery. Pharm. Res. 25, 1412-1419. (doi:10.1007/s11095-008-9542-2)
41. Williams, A. & Barry, B. 2004 Penetration enhancers. Adv. Drug Deliv. Rev. 56, 603-618. (doi:10.1016/j.addr.2003.10.025)
42. Yamawaki, H. & Iwai, N. 2006 Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am. J. Physiol. Cell Physiol. 290, C1495-C1502. (doi:10.1152/ajpcell. 00481.2005)
43. Yoo, J., Doshi, N. & Mitragotri, S. 2009 Endocytosis and intracellular distribution of PLGA particles in endothelial cells: effect of particle geometry. Macromol. Rapid Commun. 31, 142-148. (doi:10.1002/marc. 200900592)